Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

BIRC3 but Not BIRC2 mRNA Expression in Chronic Lymphocytic Leukemia Correlates with Disease Progression and Mediates Decreased Fludarabine Sensitivity in Vitro

Daniela Asslaber, PhD, Josefina D. Pinon Hofbauer, PhD, Nadja Zaborsky, PhD, Thomas Kocher, MSc, Tanja N. Hartmann, PhD, Richard Greil, MD, Alexander Egle, MD

Blood (2012) 120 (21): 563.

https://doi.org/10.1182/blood.V120.21.563.563

Published: 2012

Journal Articles

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia

Daniela Asslaber, Josefina D. Piñón, Irina Seyfried, Petra Desch, Markus Stöcher, Inge Tinhofer, Alexander Egle, Olaf Merkel, Richard Greil

Blood (2010) 115 (21): 4191–4197.

https://doi.org/10.1182/blood-2009-07-234823

Published: 2010

Journal Articles

PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia

Claudia Holler, Josefina D. Piñón, Ursula Denk, Christoph Heyder, Sebastian Hofbauer, Richard Greil, Alexander Egle

Blood (2009) 113 (12): 2791–2794.

https://doi.org/10.1182/blood-2008-06-160713

Published: 2009

Includes: Supplemental data

Journal Articles

T Cell Dynamics during the Pretumor and Tumor Phase in the Murine Tcl1 Transgenic Chronic Lymphocytic Leukemia Model

Alexander Egle, MD, Josefina D. Pinon, Christoph Heyder, Claudia Holler, Ursula Denk, Inge Tinhofer, PhD, Richard Greil

Blood (2008) 112 (11): 3145.

https://doi.org/10.1182/blood.V112.11.3145.3145

Published: 2008

Journal Articles

PKCβ Is Essential for the Development of CLL in the TCL1 Transgenic Mouse Model: Validation of PKCβ as a Therapeutic Target in CLL

Alexander Egle, MD, Claudia Holler, Josefina D. Pinon, Ursula Denk, Christoph Heyder, Richard Greil

Blood (2008) 112 (11): 4164.

https://doi.org/10.1182/blood.V112.11.4164.4164

Published: 2008

NARROW

BIRC3 but Not BIRC2 mRNA Expression in Chronic Lymphocytic Leukemia Correlates with Disease Progression and Mediates Decreased Fludarabine Sensitivity in Vitro

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia

PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia

T Cell Dynamics during the Pretumor and Tumor Phase in the Murine Tcl1 Transgenic Chronic Lymphocytic Leukemia Model

PKCβ Is Essential for the Development of CLL in the TCL1 Transgenic Mouse Model: Validation of PKCβ as a Therapeutic Target in CLL

Email alerts

ASH Publications

American Society of Hematology

BIRC3 but Not BIRC2 mRNA Expression in Chronic Lymphocytic Leukemia Correlates with Disease Progression and Mediates Decreased Fludarabine Sensitivity in Vitro

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia

PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia

T Cell Dynamics during the Pretumor and Tumor Phase in the Murine Tcl1 Transgenic Chronic Lymphocytic Leukemia Model

PKCβ Is Essential for the Development of CLL in the TCL1 Transgenic Mouse Model: Validation of PKCβ as a Therapeutic Target in CLL

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only